Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase

Synthesis and biological activity of a bivalent nucleotide inhibitor of ribonucleotide reductase Ribose-Modified Purine Nucleosides as Ribonucleotide Reductase Inhibitors. Synthesis, Antitumor Activity, and Molecular Modeling of N⁶-Substituted 3′-C-Methyladenosine Derivatives Antitumor Activity of C-Methyl-β-<scp>d</scp>-ribofuranosyladenine Nucleoside Ribonucleotide Reductase Inhibitors Nucleosides and nucleotides. 142. an alternative synthesis of and its antiviral activity From the covalent linkage of drugs to novel inhibitors of ribonucleotide reductase: Synthesis and biological evaluation of valproic esters of 3′-C-methyladenosine 2'-Deoxy-2'-methylenecytidine and 2'-deoxy-2',2'-difluorocytidine 5'-diphosphates: potent mechanism-based inhibitors of ribonucleotide reductase Potential inhibitors of nucleotide biosynthesis. 1. Nitrosoureidonucleosides. 2 Purine and 1-deazapurine ribonucleosides and deoxyribonucleosides: synthesis and biological activity The synthesis of acyclonucleoside hydroxamic acids as inhibitors of ribonucleotide reductase Synthesis of hydroxy- and amino-substituted benzohydroxamic acids: inhibition of ribonucleotide reductase and antitumor activity